REGENEREX PHARMA, INC. (RGPX) Cash flow

Market cap
P/E ratio
2011/112012/112013/112014/112018/032019/032020/032021/032022/032023/032024/032025/03
Stock-based compensation----10,25045,000--45,000-211,698132,662
Cash from operations ---54,323-71,64136,12247,059291,179-62,652-64,412-76,164-457,548-1,625,351
Cash from investing ---10,000-10,000-16,000--6,000--8,600-1,398-6,299-1,228
Cash from financing 94,501170,408215,614288,41753,850133,877214,09364,09474,26076,057463,0842
AI Chat